# A phase II study of capecitabine and lapatinib in advanced refractory colorectal adenocarcinoma: A Wisconsin Oncology Network study.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-ii-study-of-capecitabine-and-lapatinib-in-advanced-refractory-colorectal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Daniel Frank,Alcee Jumonville,Noelle K. LoConte,William R. Schelman,Daniel Mulkerin,Sam Joseph Lubner,Katie Richter,Natalie Winterle,Mary Beth Wims,Leah L. Dietrich,Jelena Winkler,Michael Volk,KyungMann Kim,Kyle D. Holen |
| Citations | 21 |
| DOI | 10.3978/j.issn.2078-6891.2011.049 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/3397648 |
| OpenAlex ID | https://openalex.org/W1549224567 |
| PMID | 22811876 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Leah L. Dietrich](https://scholariq.org/researchers/leah-l-dietrich/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.